Skip to content

Discontinued — last reported Q3 '16

Gross margin at other companies

Amgen logo
AmgenAMGN
68.3%+5.3pp
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
60.8%+1.5pp
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
96.1%-2.7pp
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
100%+31.2pp
TG Therapeutics logo
TG TherapeuticsTGTX
83.1%-4.4pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
95.1%-0.2pp

Other financials

Income statement

See full
Revenue$141.0K+95.8%
Operating income-$116.2M-23.8%
Net income-$104.9M-20.7%
EPS (diluted)-$1.15-5.5%

Balance sheet

See full
Cash & equivalents$176.3M+51.7%
Total debt$36.8M+59.4%
Total equity$636.0M+5.2%
Total assets$789.0M+19.4%

Cash flow

See full
Operating cash flow-$119.7M-29.1%
CapEx$23.0K-73.3%
Free cash flow-$119.7M-29.0%

Valuation

See full
Market cap$1.91B+82.0%
Enterprise value$1.77B+85.0%
P/S26.9×-3,445×

Profitability

See full
Operating margin-543.9%-271pp
Net margin-508.5%-254pp
FCF margin-428.4%-214pp

Returns & leverage

See full
Return on equity-58.1%+7.9pp
Debt / equity0.1×0.0×
Current ratio15.1×-4.3×

Where this comes from

Calculated from Viridian Therapeutics, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Viridian Therapeutics, Inc.’s 10-Q, filed November 9, 2017, on SEC EDGAR. View the filing →

Questions, answered.

What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.